Emory to Use Synamatix Tools for Cognitive Disease Studies | GenomeWeb
NEW YORK (GenomeWeb News) — Synamatix yesterday said it will help researchers at Emory University process and analyze small RNAs found in cognitive disease studies of mouse brains.
 
Synamatix, based in Kuala Lumpur, said it will apply its SynaBASE and SXOligoSearch pattern-finding platforms to data collected from neurological studies conducted by the Emory University School of Medicine.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.